17-50836049-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_175575.6(WFIKKN2):āc.112A>Gā(p.Ile38Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00242 in 1,604,616 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_175575.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WFIKKN2 | NM_175575.6 | c.112A>G | p.Ile38Val | missense_variant | 1/2 | ENST00000311378.5 | NP_783165.1 | |
WFIKKN2 | NM_001330341.2 | c.-70+1017A>G | intron_variant | NP_001317270.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WFIKKN2 | ENST00000311378.5 | c.112A>G | p.Ile38Val | missense_variant | 1/2 | 1 | NM_175575.6 | ENSP00000311184.4 | ||
WFIKKN2 | ENST00000426127.1 | c.-70+1017A>G | intron_variant | 2 | ENSP00000405889.1 |
Frequencies
GnomAD3 genomes AF: 0.00168 AC: 255AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00144 AC: 329AN: 228606Hom.: 0 AF XY: 0.00147 AC XY: 183AN XY: 124158
GnomAD4 exome AF: 0.00250 AC: 3634AN: 1452268Hom.: 4 Cov.: 31 AF XY: 0.00246 AC XY: 1774AN XY: 721640
GnomAD4 genome AF: 0.00167 AC: 254AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.00160 AC XY: 119AN XY: 74516
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.112A>G (p.I38V) alteration is located in exon 1 (coding exon 1) of the WFIKKN2 gene. This alteration results from a A to G substitution at nucleotide position 112, causing the isoleucine (I) at amino acid position 38 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at